Opko Health Statistics
Opko Health (XCY) Stock Statistics & Valuation Metrics
Total Valuation
Opko Health has a market cap or net worth of EUR 1.14B. The enterprise value is EUR 1.33B.
- Market Cap
- EUR 1.14B
- Enterprise Value
- EUR 1.33B
Share Statistics
Opko Health has 742,506,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 742,506,500
- Owned by Insiders
- 37.41%
- Owned by Institutions
- 16.60%
Financial Efficiency
Opko Health’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -11.32%.
- Return on Equity (ROE)
- -0.18
- Return on Assets (ROA)
- -0.12
- Return on Invested Capital (ROIC)
- -11.32%
- Return on Capital Employed (ROCE)
- -0.12
- Revenue Per Employee
- 266.76K
- Profits Per Employee
- -99.20K
- Employee Count
- 2,275
- Asset Turnover
- 0.31
- Inventory Turnover
- 7.27
Valuation Ratios
The current PE Ratio of Opko Health is -8.86. Opko Health’s PEG ratio is 0.09.
- PE Ratio
- -8.86
- PS Ratio
- 2.54
- PB Ratio
- 1.14
- Price to FCF
- -9.43
- Price to Operating Cash Flow
- -10.21
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, Opko Health had revenue of 606.88M and earned -225.68M in profits. Earnings per share was -0.30.
- Revenue
- 606.88M
- Gross Profit
- 128.05M
- Operating Income
- -218.99M
- Pretax Income
- -241.39M
- Net Income
- -225.68M
- EBITDA
- -41.30M
- Earnings Per Share (EPS)
- -0.30
Cash Flow
In the last 12 months, operating cash flow was -125.05M and capital expenditures -10.29M, giving a free cash flow of -135.34M billion.
- Operating Cash Flow
- -125.05M
- Free Cash Flow
- -135.34M
- Free Cash Flow per Share
- -0.18
Dividends & Yields
Opko Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.67%
- Earnings Yield
- -11.67%
Stock Price Statistics
- Beta
- 0.80
- 52-Week Price Change
- 32.70%
- 50-Day Moving Average
- 1.36
- 200-Day Moving Average
- 1.14
- Relative Strength Index (RSI)
- 61.62
- Average Volume (3m)
- 1,500
Important Dates
Opko Health upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Opko Health as a current ratio of 3.97, with Debt / Equity ratio of 34.20%
- Current Ratio
- 3.97
- Quick Ratio
- 3.52
- Debt to Market Cap
- 0.42
- Net Debt to EBITDA
- -1.56
- Interest Coverage Ratio
- -2.02
Taxes
In the past 12 months, Opko Health has paid -15.71M in taxes.
- Income Tax
- -15.71M
- Effective Tax Rate
- 0.07
Enterprise Valuation
Opko Health EV to EBITDA ratio is -51.00, with an EV/FCF ratio of -10.29.
- EV to Sales
- 2.78
- EV to EBITDA
- -51.00
- EV to Free Cash Flow
- -10.29
- EV to Operating Cash Flow
- -11.14
Balance Sheet
Opko Health has EUR 390.22M in cash and marketable securities with EUR 514.09M in debt, giving a net cash position of -EUR 123.86M billion.
- Cash & Marketable Securities
- EUR 390.22M
- Total Debt
- EUR 514.09M
- Net Cash
- -EUR 123.86M
- Net Cash Per Share
- -EUR 0.17
- Tangible Book Value Per Share
- EUR 0.28
Margins
Gross margin is 38.64%, with operating margin of -25.46%, and net profit margin of -29.51%.
- Gross Margin
- 38.64%
- Operating Margin
- -25.46%
- Pretax Margin
- -31.72%
- Net Profit Margin
- -29.51%
- EBITDA Margin
- -5.44%
- EBIT Margin
- -23.33%
Analyst Forecast
The average price target for Opko Health is EUR 2.74, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 2.74
- Price Target Upside
- 79.06% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- -26.00%
- EPS Growth Forecast
- 22.82%
Scores
- Smart Score
- 8
- AI Score
- ―
